Hainan Huluwa Pharmaceutical Group News

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary

Jan 1 00:00

Response to the inquiry letter on abnormal fluctuations in stock trading

Dec 7, 2024 00:00

Announcement on abnormal fluctuations in stock trading of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Dec 7, 2024 00:00

Huluwa: Announcement on Abnormal Stock Trading Fluctuations and Risk Alerts for Hainan Huluwa Pharmaceutical Group Co., Ltd.

Dec 5, 2024 00:00

Huluwa: Response to the Request Letter for Abnormal Fluctuations in Stock Trading

Dec 5, 2024 00:00

Response to the inquiry letter on abnormal fluctuations in stock trading

Dec 5, 2024 00:00

Announcement on abnormal stock trading fluctuations and risk alerts of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Dec 5, 2024 00:00

Huluwa: Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice

Dec 3, 2024 00:00

Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice

Dec 3, 2024 00:00

Announcement on abnormal fluctuations in stock trading of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Nov 30, 2024 00:00

Response to the inquiry letter on abnormal fluctuations in stock trading

Nov 30, 2024 00:00

Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice

Nov 29, 2024 00:00

Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Nov 28, 2024 00:00

Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Nov 28, 2024 00:00

An indicative announcement by Hainan Huluwa Pharmaceutical Group Co., Ltd. on changes in the equity of shareholders holding 5% or more of the shares

Nov 28, 2024 00:00

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the results of shareholders holding 5% or more of the shares reduced their holdings

Nov 28, 2024 00:00

Response to the inquiry letter on abnormal fluctuations in stock trading

Nov 28, 2024 00:00

Announcement on abnormal fluctuations in stock trading of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Nov 28, 2024 00:00

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the progress of capital increase for wholly-owned subsidiaries through debt-for-share swaps

Nov 23, 2024 00:00

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. receiving government subsidies

Nov 22, 2024 00:00